Rahul Sarugaser
Stock Analyst at Raymond James
(0.02)
# 4,426
Out of 4,847 analysts
10
Total ratings
12.5%
Success rate
-27.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rahul Sarugaser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONCY Oncolytics Biotech | Initiates: Outperform | $3 | $0.34 | +772.09% | 1 | Apr 4, 2024 | |
| QIPT Quipt Home Medical | Downgrades: Market Perform | $10 | $1.72 | +481.40% | 1 | Feb 16, 2024 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Market Perform | $100 | $7.13 | +1,302.52% | 4 | Nov 15, 2023 | |
| PROF Profound Medical | Downgrades: Outperform | n/a | $5.47 | - | 2 | Aug 4, 2023 | |
| VFF Village Farms International | Downgrades: Market Perform | $11 → $2.5 | $1.21 | +106.61% | 2 | Feb 27, 2023 | |
Oncolytics Biotech
Apr 4, 2024
Initiates: Outperform
Price Target: $3
Current: $0.34
Upside: +772.09%
Quipt Home Medical
Feb 16, 2024
Downgrades: Market Perform
Price Target: $10
Current: $1.72
Upside: +481.40%
Ginkgo Bioworks Holdings
Nov 15, 2023
Downgrades: Market Perform
Price Target: $100
Current: $7.13
Upside: +1,302.52%
Profound Medical
Aug 4, 2023
Downgrades: Outperform
Price Target: n/a
Current: $5.47
Upside: -
Village Farms International
Feb 27, 2023
Downgrades: Market Perform
Price Target: $11 → $2.5
Current: $1.21
Upside: +106.61%